By Rachael Levy (Reuters) – Elon Musk’s Neuralink, a medical device company, is under federal investigation for potential animal-welfare violations…
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
By Blake Brittain (Reuters) -Pfizer Inc and its German partner, BioNTech SE, fired back at Moderna Inc on Monday in…
Foxconn sees COVID-hit China plant back at full output in late Dec-early Jan -source
By Yimou Lee TAIPEI (Reuters) – Apple supplier Foxconn expects its COVID-hit Zhengzhou plant in China to resume full production around…
Investors bet China’s rally on easing COVID curbs will be furious but fleeting
By Jason Xue and Summer Zhen SHANGHAI/HONG KONG (Reuters) – Investors piling into China’s tourism, catering and beverage stocks as…
Philippines trims 2023 GDP growth target due to global risks
By Neil Jerome Morales and Karen Lema MANILA (Reuters) – The Philippines on Monday lowered its economic growth target for…
No plans to go back to Congress to change inflation act – White House
WASHINGTON (Reuters) – There are no plans to go back to Congress to push for changes to the Inflation Reduction…
Reckitt expects U.S. infant formula shortage until spring
By Richa Naidu LONDON (Reuters) -The near year-long infant formula shortage in the United States that prompted the intervention of…
IMF’s Georgieva to press for quicker action on debt relief with China
By Andrea Shalal NEW YORK (Reuters) -International Monetary Fund Managing Director Kristalina Georgieva said on Thursday that she will travel…
Elon Musk expects Neuralink’s brain chip to begin human trials in 6 months
By Rachael Levy (Reuters) -Elon Musk said on Wednesday he expects a wireless brain chip developed by his company Neuralink…
REUTERS NEXT: IMF chief sees higher chance of global growth below 2% in 2023
By Andrea Shalal and David Lawder NEW YORK (Reuters) – International Monetary Fund Managing Director Kristalina Georgieva said on Thursday…